Kevin McHugh is a Global Technology Expert in the Cell Culture Technologies department at Sartorius-Stedim Biotech, who focuses on the ambr product line. He has worked on multi-parallel bioreactors for over 8 years. In his current role Kevin works to shape the development and direction of the ambr product line. He explores technology integrations, investigates customer needs, examines developments, and explores new application areas for the ambr product line. Prior to Sartorius Kevin spend 6 years working in the biopharmaceutical industry at Glaxo Smith Kline and Sanofi Pasteur where he focused on research to launch microbial systems, evaluating and implementing new technologies, developing and optimize scaling models. He holds a B.S. in Bioengineering from Lehigh University.